Quantitative assessment of protein replacement in therapeutic plasmapheresis

Aim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthri...

Full description

Bibliographic Details
Main Authors: N N Kalinin, В Е Movshev, D Hester, V I Petrova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2003-02-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/29319
id doaj-74e1b07b53164ddea35ecf3bb24c95f5
record_format Article
spelling doaj-74e1b07b53164ddea35ecf3bb24c95f52020-11-25T02:38:47Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422003-02-01782656826355Quantitative assessment of protein replacement in therapeutic plasmapheresisN N KalininВ Е MovshevD HesterV I PetrovaAim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthritis, bronchial asthma, systemic lupus erythematosus and other diseases. The plasm was replaced by 0.9% sodium chloride solution, rheopolyglucine and albumin solutions in isovolemic regime. Albumin was given in quantities equivalent to 50-65% of the removed protein. Results. Close correlation was observed between the expected and actual concentrations of total protein in 96 patients who have undergone 206 TPA procedures. In removal of up to 35% CPL protein deficiency is compensated by its mobilization from the deposits and due to protein-synthetizing function of the liver. In removal of 75% and more and in initial hypoproteinemia 50% of the protein should be replaced. Conclusion. It is confirmed that rheopolyglucin can be used for plasm replacement in TPA in patients with hyperproteinemia having no contraindications.https://ter-arkhiv.ru/0040-3660/article/view/29319plasmapheresisvolume of removed plasmisovolemiacolloid-osmotic pressureprotein replacement
collection DOAJ
language Russian
format Article
sources DOAJ
author N N Kalinin
В Е Movshev
D Hester
V I Petrova
spellingShingle N N Kalinin
В Е Movshev
D Hester
V I Petrova
Quantitative assessment of protein replacement in therapeutic plasmapheresis
Терапевтический архив
plasmapheresis
volume of removed plasm
isovolemia
colloid-osmotic pressure
protein replacement
author_facet N N Kalinin
В Е Movshev
D Hester
V I Petrova
author_sort N N Kalinin
title Quantitative assessment of protein replacement in therapeutic plasmapheresis
title_short Quantitative assessment of protein replacement in therapeutic plasmapheresis
title_full Quantitative assessment of protein replacement in therapeutic plasmapheresis
title_fullStr Quantitative assessment of protein replacement in therapeutic plasmapheresis
title_full_unstemmed Quantitative assessment of protein replacement in therapeutic plasmapheresis
title_sort quantitative assessment of protein replacement in therapeutic plasmapheresis
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2003-02-01
description Aim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthritis, bronchial asthma, systemic lupus erythematosus and other diseases. The plasm was replaced by 0.9% sodium chloride solution, rheopolyglucine and albumin solutions in isovolemic regime. Albumin was given in quantities equivalent to 50-65% of the removed protein. Results. Close correlation was observed between the expected and actual concentrations of total protein in 96 patients who have undergone 206 TPA procedures. In removal of up to 35% CPL protein deficiency is compensated by its mobilization from the deposits and due to protein-synthetizing function of the liver. In removal of 75% and more and in initial hypoproteinemia 50% of the protein should be replaced. Conclusion. It is confirmed that rheopolyglucin can be used for plasm replacement in TPA in patients with hyperproteinemia having no contraindications.
topic plasmapheresis
volume of removed plasm
isovolemia
colloid-osmotic pressure
protein replacement
url https://ter-arkhiv.ru/0040-3660/article/view/29319
work_keys_str_mv AT nnkalinin quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis
AT vemovshev quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis
AT dhester quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis
AT vipetrova quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis
_version_ 1724789612542427136